Matthew Rizzo - Director, 10%+ Owner at Xtant Medical Holdings, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director, 10%+ Owner
Stock Symbol
XTNT on NYSE
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Matthew Rizzo since 9/18/2023

Holdings reported by Matthew Rizzo for Xtant Medical Holdings, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock, $0.000001 par value 17.1M $10.4M $0.61 Aug 15, 2022 Indirect
Common Stock, $0.000001 par value 215K $131K $0.61 Aug 15, 2022 Direct

Transactions reported by Matthew Rizzo for Xtant Medical Holdings, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.